2010
DOI: 10.1016/j.bjoms.2009.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 8 publications
0
19
0
1
Order By: Relevance
“…Although the anatomical localization of the submandibular gland for BTX injection study has been reported in previous studies, a comparison of the accuracy of injection into the submandibular gland using US-guided as compared to non-guided techniques has not been reported. The submandibular gland is the major gland responsible for resting saliva secretion; while the parotid gland is predominantly active during mastication [6]. Patients with neurological disorders often suffer from drooling while in the resting state rather than during eating.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the anatomical localization of the submandibular gland for BTX injection study has been reported in previous studies, a comparison of the accuracy of injection into the submandibular gland using US-guided as compared to non-guided techniques has not been reported. The submandibular gland is the major gland responsible for resting saliva secretion; while the parotid gland is predominantly active during mastication [6]. Patients with neurological disorders often suffer from drooling while in the resting state rather than during eating.…”
Section: Discussionmentioning
confidence: 99%
“…In previous studies, BTX injection procedures were performed blind using anatomical landmarks or ultrasound (US) guidance [3]. The risks of the procedure include induced weakness of the adjacent muscles, leading to a difficulty in swallowing due to an incorrect injection of the toxin into the masseter or pharyngeal muscles [6]. Other potential risks include hematoma and injury to the carotid arteries or the facial nerve.…”
Section: Introductionmentioning
confidence: 99%
“…The therapeutic application has been extended to various clinical disorders, including salivary secretory diseases [15]. In the isolated pathology of one parotid, especially when connected with salivary secretion leakage, the value of the method is even higher than oral antisialogogues and anticholinergic medications that inhibit the total neural stimulation.…”
Section: Discussionmentioning
confidence: 99%
“…Botulinum toxin injection administered during the procedure to decrease the secretion of saliva can improve the healing process. The therapeutic application of botulinum toxin has been extended to various clinical disorders, including salivary secretory diseases [15]. In the isolated pathology of one parotid, especially when connected with salivary secretion leakage, the method could be a valuable alternative to oral antisialogogues and anticholinergic medications that inhibit total neural stimulation [69].…”
Section: Introductionmentioning
confidence: 99%
“…BTA, an exotoxin produced by Clostridium botulinum , has been described as a means of decreasing saliva production4 due to its anticholinergic effect on the parasympathetic secretomotor fibres of the salivary gland and its use is well recognised in neuromuscular disorders and salivary gland problems 7. There are isolated reports describing its use in post-traumatic salivary fistula where BTA has been either infiltrated around fistula or injected into the gland.…”
Section: Discussionmentioning
confidence: 99%